Atria Investments’s iShares iBonds Dec 2030 Term Corporate ETF IBDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.29M Buy
288,553
+38,779
+16% +$846K 0.06% 329
2026
Q1
$5.47M Buy
249,774
+16,168
+7% +$357K 0.06% 348
2025
Q4
$5.16M Buy
233,606
+223,981
+2,327% +$4.95M 0.06% 369
2025
Q3
$213K Buy
9,625
+189
+2% +$4.16K ﹤0.01% 1915
2025
Q2
$207K Sell
9,436
-152,961
-94% -$3.31M ﹤0.01% 1909
2025
Q1
$3.53M Buy
162,397
+71,580
+79% +$1.54M 0.05% 481
2024
Q4
$1.94M Buy
90,817
+11,523
+15% +$249K 0.02% 691
2024
Q3
$1.76M Buy
79,294
+8,110
+11% +$177K 0.02% 713
2024
Q2
$1.51M Buy
71,184
+19,338
+37% +$408K 0.02% 754
2024
Q1
$1.11M Buy
+51,846
New +$1.11M 0.02% 908

Other funds holding IBDV

Atria Investments's IBDV Position: Q2 2026 in Review

Atria Investments increased its iShares iBonds Dec 2030 Term Corporate ETF (IBDV) stake by 16% in Q2 2026, buying an estimated $846K and bringing the position to 288,553 shares worth $6.29M. The position accounts for 0.06% of the portfolio, ranked #329.

Atria Investments first reported a position in IBDV in Q1 2024 and has held it in 10 quarters since. 350 funds tracked by Wall St. Rank hold IBDV as of Q2 2026.

  • Atria Investments held 288,553 shares of iShares iBonds Dec 2030 Term Corporate ETF worth $6.29M as of Q2 2026.
  • Atria Investments bought 38,779 iShares iBonds Dec 2030 Term Corporate ETF shares in Q2 2026, an estimated $846K.
  • iShares iBonds Dec 2030 Term Corporate ETF made up 0.06% of Atria Investments's portfolio in Q2 2026, its #329 holding.
  • Atria Investments first reported a position in iShares iBonds Dec 2030 Term Corporate ETF in Q1 2024 and has held it in 10 quarters since.
  • 350 funds tracked by Wall St. Rank held iShares iBonds Dec 2030 Term Corporate ETF as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.